GEGAX
Price
$13.41
Change
-$0.25 (-1.83%)
Updated
Sep 6 closing price
VEMAX
Price
$36.26
Change
-$0.52 (-1.41%)
Updated
Sep 6 closing price
Ad is loading...

GEGAX vs VEMAX

Header iconGEGAX vs VEMAX Comparison
Open Charts GEGAX vs VEMAXBanner chart's image
abrdn Emerging Markets A
Price$13.41
Change-$0.25 (-1.83%)
VolumeN/A
CapitalizationN/A
Vanguard Emerging Mkts Stock Idx Adm
Price$36.26
Change-$0.52 (-1.41%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
GEGAX vs VEMAX Comparison Chart
Loading...
VS
GEGAX vs. VEMAX commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GEGAX is a Buy and VEMAX is a Buy.

FUNDAMENTALS
Fundamentals
VEMAX has more cash in the bank: 108B vs. GEGAX (1.26B). VEMAX pays higher dividends than GEGAX: VEMAX (3.43) vs GEGAX (0.87). GEGAX was incepted earlier than VEMAX: GEGAX (12 years) vs VEMAX (18 years). GEGAX is a more actively managed with annual turnover of: 30.01 vs. VEMAX (5.00). GEGAX has a lower initial minimum investment than VEMAX: GEGAX (1000) vs VEMAX (3000). VEMAX annual gain was more profitable for investors over the last year : 11.57 vs. GEGAX (7.79). VEMAX return over 5 years is better than : 17.50 vs. GEGAX (-5.58).
GEGAXVEMAXGEGAX / VEMAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years18 years-
Gain YTD4.6747.97159%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRA1000N/A-
Net Assets1.26B108B1%
Annual Yield % from dividends0.873.4326%
Returns for 1 year7.7911.5767%
Returns for 3 years-32.81-10.40315%
Returns for 5 years-5.5817.50-32%
Returns for 10 years-7.8214.03-56%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ZKIN0.470.01
+2.60%
ZK International Group Co Ltd
IMAX21.860.26
+1.20%
Imax Corp
PKX63.88-0.63
-0.98%
POSCO Holdings
TGTX21.46-0.62
-2.81%
TG Therapeutics
CMPX1.49-0.05
-3.25%
Compass Therapeutics